In chronic kidney disease, EPO production is usually in a disruption state, leading to a decrease in Hb (Hb < 13 g/dl for men and <12 g/dl for women) (Coresh et al., 2007), labeled as renal anemia. Here, GSTM1 is linked to chronic kidney disease.